Request To Download Free Sample of This Strategic Report @- The Global Remote Patient Monitoring Devices Market is on the brink of transformative growth, poised to exceed USD 1,882.75 Million by 2025 ...

Companies with PCR-on-a-card technology include Roche, Caliper Life Sciences and ... Among them is California-based Pelikan Technologies, with a blood glucose monitoring device due to be launched ...

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of Alzheimer’s disease. The two plasma-based, in vitro tests scan for specific ...

Data from two Alzheimer’s tests being developed by Roche Holding AG showed high accuracy in detecting the disease in patients being tested for the condition. The tests measure biomarkers in the blood ...

Tamar is a Registered Dietitian and marathon runner who has served in the Israel Defense Forces (IDF) for two years as a combat fitness instructor. Kristie Reed, PharmD, oversees emergency ...

AbbVie inks $1.4B Aliada buyout, landing ex-J&J Alzheimer's drug to leap the blood-brain barrier As for Roche, the trial remains active, with researchers deeming trontinemab to have “an overall ...

Roche doesn’t think so. “I think we don’t see anything that should be slowing Vabysmo momentum down,” Teresa Graham, CEO of Roche Pharmaceuticals, said during a press conference Wednesday ...

Roche Diabetes Care’s Michael Goetzl explains how the company is spearheading a combined digital-pharmaceutical approach to diabetes and how pharma firms can best embrace holistic strategies.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...